Multiple-dose containers will lead ophthalmic eye drop sales through 2036 with 72.0% of container demand in 2026, as repeat-use bottle supply dominates routine therapy. The industry reached USD 18.3 billion in 2025 and is expected to reach USD 30.2 billion by 2036, an incremental opportunity of USD 11.1 billion.